semaglutide; diabetes; insulin; obesity

Fast Money host Melissa Lee talks with CNBC’s DJ Sixsmith about “Big Shot: The Ozempic Revolution,” which premieres on Thursday, February 29 at 10 pm ET. In this one-hour documentary, CNBC takes a deep dive into the global anti-obesity drug market, exploring the risks people are taking to get...

Aaron Rand, Bill Brownstein, and Leslie Chesterman discuss weight loss and Ozempic ahead of the upcoming eating binge commonly known as Christmas with Dr. Joe Schwarcz, Director of McGill University's Office for Science and Society which has the mission of separating sense from nonsense.

https://www.hcplive.com/view/diabetes-dialogue-making-sense-of-semaglutide-in-type-1-diabetes In this episode, hosts sit down for a discussion around a recent NEJM report assessing the effects of semaglutide use in people with type 1 diabetes, including the implications of the findings and...

https://www.hcplive.com/view/semaglutide-could-eliminate-need-for-insulin-in-type-1-diabetes A case series of 10 patients with newly diagnosed type 1 diabetes provides insight into the beneficial effects of off-label semaglutide use on insulin use, HbA1c, and fasting C-peptide levels among...